INEX Chief Executive Kane Black on Innovating the Future of BiotechnologyÂ
LUXUO speaks to the man making waves in medical reseach and innovations in the biotechnology sector alongside the growth of INEX
The post INEX Chief Executive Kane Black on Innovating the Future of Biotechnology appeared first on LUXUO.
INEX Innovate’s chief executive Kane Black
What brought you into the field of diagnostic research"
Having been in the life sciences industry for several years on the investment side, diagnostics was a crucial part that one of my original co-founder’s, Ivanna Salehudin and I, saw significant unmet clinical needs, specifically around women?s health. The importance of diagnostics cannot be overestimated, as without the availability of accurate diagnostics you don?t have therapy.
This culminated in the establishment of Nova Satra Dx Pte Ltd – which began research & development into a highly accurate liquid biopsy, or blood based, breast cancer diagnostic test, a company later backed by Malaysian conglomerate Genting Berhad. In 2019 following several meetings with the original founders of INEX Innovations Exchange ? Prof Mahesh Choolani and Dr. Sidney Yee together with medtech investor Kok Hwee Sim ? we saw an opportunity to bring together, by way of a merger, Singapore?s two women?s health life sciences companies ? this led to the creation of what is now known as INEX Innovate Pte Ltd.
Since then, the company has rapidly grown from 10 team members to 55 members, with 35 in Singapore ...
The post INEX Chief Executive Kane Black on Innovating the Future of Biotechnology appeared first on LUXUO.
INEX Innovate’s chief executive Kane Black
What brought you into the field of diagnostic research"
Having been in the life sciences industry for several years on the investment side, diagnostics was a crucial part that one of my original co-founder’s, Ivanna Salehudin and I, saw significant unmet clinical needs, specifically around women?s health. The importance of diagnostics cannot be overestimated, as without the availability of accurate diagnostics you don?t have therapy.
This culminated in the establishment of Nova Satra Dx Pte Ltd – which began research & development into a highly accurate liquid biopsy, or blood based, breast cancer diagnostic test, a company later backed by Malaysian conglomerate Genting Berhad. In 2019 following several meetings with the original founders of INEX Innovations Exchange ? Prof Mahesh Choolani and Dr. Sidney Yee together with medtech investor Kok Hwee Sim ? we saw an opportunity to bring together, by way of a merger, Singapore?s two women?s health life sciences companies ? this led to the creation of what is now known as INEX Innovate Pte Ltd.
Since then, the company has rapidly grown from 10 team members to 55 members, with 35 in Singapore ...
-------------------------------- |
|